Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesBisphosphonates in breast cancer: teaching an old dog new tricks
Current Opinion in Oncology, 10/12/09
Winter MC et al. – Bisphosphonates are comprehensively established in the treatment of metastatic bone disease and significantly reduce skeletal morbidity. Their role in the prevention of cancer treatment–induced bone disease is also defined. The potential antitumour and disease–modifying role of adjuvant bisphosphonates holds promise but results from ongoing studies must be awaited before this becomes standard practice.
Related Articles
Bisphosphonates and oral surgery
Oral Surgery, 11/17/09
Relevance Score: 89%
Extended Use of Intravenous Bisphosphonate Therapy for the Prevention of Skeletal Complications in Patients with Cancer
Cancer Investigation, 11/16/09
Relevance Score: 88%
Osteogenesis imperfecta: questions and answers
Current Opinion in Pediatrics, 11/13/09
Relevance Score: 88%
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/10/09
Relevance Score: 88%
Identification of Dynamin-2-mediated Endocytosis as a New Target of Osteoporosis Drugs, Bisphosphonates
Molecular Pharmacology, 11/13/09
Relevance Score: 87%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
The risk for breast cancer is not evidently increased in women with hyperprolactinemia
Pituitary, 12/20/09
Extracellular Signal–Regulated Kinase Signaling Pathway Regulates Breast Cancer Cell Migration by Maintaining slug Expression
Cancer Research, 12/20/09
Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
Cancer Research, 12/19/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor